Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of disease-A review
- PMID: 32333803
- DOI: 10.1002/pd.5718
Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of disease-A review
Abstract
Diabetes is an increasingly common diagnosis among pregnant women. Pregestational diabetes is associated with an increase in many adverse pregnancy outcomes, which impact both on the woman and her fetus. The models of pregnancy care for women with diabetes are based largely on observational data or consensus opinion. Strategies for aneuploidy screening and monitoring for fetal well-being should be modified in women with diabetes. There is an increasing understanding of the mechanisms by which congenital anomalies and disorders of fetal growth occur, involving epigenetic modifications, changes in gene expression in critical developmental pathways, and oxidative stress. This knowledge may lead to pathways for improved care for these high-risk pregnancies.
© 2020 John Wiley & Sons, Ltd.
References
REFERENCES
-
- Autralian Institute of Health and Welfare. Incidence of gestational diabetes in Australia; 2019.
-
- International Diabetes Federation. International diabetes federation diabetes atlas. Brussels; 2017.
-
- Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27(12):2819-2823.
-
- Colstrup M, Mathiesen ER, Damm P, Jensen DM, Ringholm L. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning fetal and neonatal complications? J Matern Fetal Neonatal Med. 2013;26(17):1682-1686.
-
- Tennant PW, Glinianaia SV, Bilous RW, et al. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57(2):285-294.